Press release
Masimo Files Investor Presentation Highlighting Track Record of Success, Compelling Strategy, Responsive Governance Changes and Risks Posed by Quentin Koffey’s Agenda
Masimo’s Leadership Has Delivered Strong Returns for Investors through Sustained Profitable Above-Market Growth Masimo’s Strategy Leverages Core Competencies
About this update from Masimo Corporation
[{"type":"text","content":"\nMasimo’s Leadership Has Delivered Strong Returns for Investors through Sustained Profitable Above-Market Growth\n\n\nMasimo’s Strategy Leverages Core Competencies to Extend Growth in Core and New Markets, Create Value for All Shareholders\n\n\nMasimo’s Board Has Engaged Extensively with Shareholders and Acted on Their Feedback\n\n\nQuentin Koffey’s Unprincipled, Self-Serving Behavior and Dangerous Agenda Jeopardize Masimo’s Long-Term Potential\n\n\nStrongly Encourages Stockholders to Protect Their Investment by Voting FOR H Michael Cohen and Julie Shimer, Ph.D., on the WHITE Proxy Card\n\n\nVisit KeepMasimoStrong.com for More Information\n\n\n IRVINE, Calif.--(BUSINESS WIRE)--\nMasimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI) today filed an investor presentation with the U.S. Securities and Exchange Commission in connection with its Annual Meeting of Stockholders to be held on June 26, 2023. The presentation outlines why the management team and Board of Directors are well-positioned to continue delivering strong returns to all stockholders and details the risk that Politan Capital Management (“Politan”) and its nominee Quentin Koffey pose to the Company’s strategy, principles and leadership. To protect stockholders’ investment and to ensure Masimo continues to create value, the Board encourages stockholders to vote FOR Masimo’s highly qualified director nominees, H Michael Cohen and Julie Shimer, Ph.D.\n\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230531005488/en/\nThe presentation is available via the multimedia version of this press release.\n\n\nAbout Masimo\n\n\nMasimo (Nasdaq: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. In addition, Masimo Consumer Audio is home to eight legendary audio brands, including Bowers & Wilkins™, Denon™, Marantz™, and Polk Audio™. Our mission is to improve life, improve patient outcomes; and reduce the cost of care. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies. Masimo SET® has al...